Talecris Biotherapeutics Holdings Corp.Research Triangle Park, NC, United States (NASDAQ (GM): TLCR Proposed)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Talecris Cash Flow Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 06 Dec 05 Dec 04
Net Operating Cash Flow 138.0 87.5 (45.2)
Net Investing Cash Flow (152.2) (294.3) (23.5)
Net Financing Cash Flow 14.3 217.7 68.7
Net Change in Cash 0.2 10.9 0.0
Depreciation & Amortization -- -- --
Capital Expenditures (38.9) (30.4) (24.1)
Cash Dividends Paid (809.8) (23.4) 0.0